PATENT CLAIM ANALYSIS

Application Number: 15872498
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "158100"]

Abstract:
Described are single domain antibodies with a specificity for BACE1. More specifically, described are single variable-domain antibodies derived from camelids that bind to BACE1 and are capable of inhibiting the activity of BACE1. The antibodies can be used for research and medical applications. Specific applications include the use of BACE1-specific antibodies for the treatment of Alzheimer's disease.

Claim (Index 17):
The single-domain antibody of  claim 10 , wherein the single-domain antibody is bi-specific.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.46512
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14023586', '12736389', '13377508', '15234649', '14292461']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7590174654755638
- 35 USC 102 Novelty (BERT): 0.5292382987901355
- Combined Prediction Score: 0.736039548807021
- Mean Citation Score: 266.514898
- Max Citation Score: 341.05063
- Similarity Product: 254.9941968819093

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test